The company just posted really solid numbers - revenue up around 10%, earnings beat expectations, full-year guidance reaffirmed - all the stuff you’d think would send the stock up. But the share price is still kind of dragging and lagging the broader market, nowhere near the recent highs. It feels like no one cares about the good news because everyone’s worried about margins in the pharmacy benefit side and overall profit pressure. It’s weird watching strong results translate into “meh” stock performance.
There are no replies in this thread yet. Be the first to post a reply below: